Role of adhesion molecules in cancer;Rola cza̧steczek adhezyjnych w chorobie nowotworowej

Polski Merkuriusz Lekarski

Volumn 13, Issue 76, 2002, Pages 345-348

  Izycka, Aneta ^a   Jabłońska, Ewa ^a  

^a Zakład Immunologii AM ^*  (Poland)

Author keywords

Adhesion molecules; Cancer

Indexed keywords

CADHERIN; CELL ADHESION MOLECULE; CELL SURFACE PROTEIN; HERMES ANTIGEN; INTEGRIN; SELECTIN; INTERCELLULAR ADHESION MOLECULE 1;

CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER RESEARCH; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; REVIEW; TUMOR GROWTH; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; NEOPLASM;

ANTIGENS, CD44; CADHERINS; CELL ADHESION MOLECULES; HUMANS; IMMUNOTHERAPY; INTEGRINS; INTERCELLULAR ADHESION MOLECULE-1; NEOPLASMS; SELECTINS;

EID: 0036427353     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Anastassiou G. i wsp.: Expression of the cell adhesion molecules ICAM-1, VCAM-1 and NCAM in uveal melanoma: A clinicopathological study. Oncology, 2000, 58, 83-88.
2. Bendall L. i wsp.: GM-CSF enhances IL-2 activated NK cell lisis of clonic AML cells by upregulating target cell expression of ICAM-1. Leukemia, 1995, 9, 677.
3. Berg E.L. i wsp.: A carbohydrate domain common to both sialyl Lea and sialyl Lex is recognised by the endothelial cell leukocyte adhesion molecule ELAM-1. J Biol. Chem., 1991, 288, 14, 869-872.
4. Bevilaccoua M.P., Nelson R.M.: Endothelial - Leucocyte adhesion molecules in inflammation and metastasis. Thromb. Haemost., 1993, 70, 152-154.
5. Birchmeier W. i wsp.: Molecular mechanism leading to cell junction (cadherin) deficiency in invasive carcinomas. Sem. Cancer Biol., 1993, 4, 231.
6. Cox D. i wsp.: The pharmacology of the integrins. Med. Res. Rev., 1994, 14, 195.
7. Foxall C. i wsp.: The three members of the selectin receptor family recognise a common carbohydrate epitope, the sialyl Lewis oligosaccharide. J. Cell Biol., 1991, 113, 173-185.
8. Geiger B., Ayalon O.: Cadherins. Ann. Rev. Cell Biol., 1992, 8, 307-332.
9. Günthert U.: A Multitude of Isoforms with Diverse Functions. W: Current Topics in Microbiology and Immunology. Springer-Verlag, Berlin 1993, 184, 47.
10. Guo Y.J. i wsp.: Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res., 1994, 54, 422-426.
11. Guo Y.J. i wsp.: Inhibition of human melanoma growth and metastasis in vivo by anti CD44 monoclonal antibody. Cancer Res., 1994, 54, 1561-1565.
12. Hirano N. i wsp.: Expression of costimulatory molecules in human leukemias. Leukemia, 1996, 10, 1168-76.
13. Janeway C.A., Travers P.: Immunobiology: The Immune System in Health and Disease. Garland, New York 1996, 5-35.
14. Jiang Z. i wsp.: Expression of ICAM-1, VCAM-1 and LFA-1 in adenocarcinoma of the lung with observations on the expression of these adhesion molecules in non-neoplastic lung tissue. Modern Pathology, 1998, 11, 1189.
15. Juliano L.R., Varner J.A.: Adhesion molecules in cancer. The role of integrins. Curr. Opin. Cell Biol., 1993, 5, 812-818.
16. Kuppner M.C. i wsp.: Activation and adhesion molecule expression on lymphoid infiltrates in human glioblastomas. J. Neuroimmunol., 1990, 29, 229-38.
17. Lesley J. i wsp.: CD44 and its interaction with the intercellular matrix. Adv. Immunol., 1993, 54, 271.
18. Ley K.: Molecular mechanism of leucocyte rolling and adhesion to microvascular endothelium. Eur. Heart. J., 1993, 14 (suppl.), 68-73.
19. Loeffler C.M. i wsp.: Immunoregulation in cancer-bearing hosts. J. Immunol., 1992, 149, 949.
20. Merogi A.J. i wsp.: Tumor-host interaction: Analysis of cytokines, growth factors, and tumor infiltrating lymphocytes in ovarian carcinomas. Hum. Pathol., 1997, 28, 231.
21. Mielcarek M. i wsp.: Expression of ICAM-1 in childhood acute lymphoblastic leucaemia: Correlation with clinical features and outcome. Br. J. Haemat., 1997, 96, 301-307.
22. Nigam A.K.L.: Adhesion molecules in cancer. Eur. J. Surg. Oncol., 1994, 20, 82-84.
23. Picker L.J. i wsp.: The neutrophil selectin LECAM-1 present carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140. Cell, 1991, 66, 921-933.
24. Shimizu Y. i wsp.: Seum concentrationn of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is marker of the disease progression and prognosis. Hepatol., 1995, 22, 525-531.
25. Sprenger A. i wsp.: Soluble intercellular adhesion molecule-1 in patients with lung cancer and bening lung diseases. J. Cancer Res. Clin. Oncol., 1997, 123, 632.
26. Springer T.A.: Adhesion receptors of the immune system. Nature, 1990, 346, 425-434.
27. Stad R.K., Buurman W.A.: Current views on structure and function of endothelial adhesion molecules. Cell. Adhes. Commun., 1994, 2, 261-268.
28. Thompson A.W. i wsp.: Circulating intercellular adhesion molecule - (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine - Stimulated human hepatocytes. Clin. Exp. Immunol., 1994, 95, 83-90.
29. Velikova G. i wsp.: Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer. Br. J. Cancer, 1997, 76, 1398.
30. Welpy J.K. i wsp.: Selectin as potential targets of therapeutic intervention in inflammatory diseases. Biochim. Bophys. Acta, 1994, 1197, 215.
31. Zak I.: Receptory adhezyjne. Post. Biol. Kom., 1996, 2, 221-242.
32. Zeromski J.: Immunologia. Wyd. Med. Słotwiński Verlag, 1996.